Trials / Completed
CompletedNCT00910078
Serum Free Light Change in Multiple Myeloma
Serum Free Light Chain Ratio, Total Kappa/Lambda Ratio, and Immunofixation as Prognostic Factors in Multiple Myeloma.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Azienda Ospedaliera San Giovanni Battista · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the predictive role of free Kappa/Lambda ration in Multiple Myeloma post-transplant.
Conditions
Timeline
- First posted
- 2009-05-29
- Last updated
- 2009-05-29
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00910078. Inclusion in this directory is not an endorsement.